Positive MHRA decision for Briviact
MHRA extends UCB’s therapy for the treatment of partial-onset seizures
Read More
Tag: Briviact
SMC clears use of five news drugs on NHS Scotland
Scottish cost regulators have endorsed the use of five new medicines by NHS Scotland, offering patients new options for lung cancer, depression, ankylosing spondylitis and epilepsy.
Read More
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
